Grifols, S.A Total Assets 2012-2025 | GRFS

Grifols, S.A total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Grifols, S.A total assets for the quarter ending March 31, 2025 were $22.101B, a 1.29% decline year-over-year.
  • Grifols, S.A total assets for 2024 were $23.163B, a 0.19% decline from 2023.
  • Grifols, S.A total assets for 2023 were $23.206B, a 2.28% increase from 2022.
  • Grifols, S.A total assets for 2022 were $22.688B, a 0.3% decline from 2021.
Grifols, S.A Annual Total Assets
(Millions of US $)
2024 $23,163
2023 $23,206
2022 $22,688
2021 $22,756
2020 $17,448
2019 $17,408
2018 $14,735
2017 $12,343
2016 $11,210
2015 $10,662
2014 $11,232
2013 $7,759
2012 $7,237
2011 $8,089
Grifols, S.A Quarterly Total Assets
(Millions of US $)
2025-03-31 $22,101
2024-06-30 $24,006
2023-06-30 $23,370
2023-03-31 $22,918
2022-06-30 $22,390
2021-06-30 $19,535
2019-06-30 $14,976
2018-06-30 $13,636
2017-06-30 $12,228
2017-03-31 $12,478
2016-12-31 $11,210
2016-09-30 $10,678
2016-06-30 $10,776
2016-03-31 $10,193
2015-12-31 $10,662
2015-09-30 $10,212
2015-06-30 $10,061
2015-03-31 $10,582
2014-12-31 $11,232
2014-09-30 $10,752
2014-06-30 $9,981
2014-03-31 $9,857
2013-12-31 $7,759
2013-09-30 $7,566
2013-06-30 $7,634
2013-03-31 $7,641
2012-12-31 $7,237
2012-09-30 $7,305
2012-06-30 $7,598
2012-03-31 $7,267
2011-12-31 $8,089
2011-09-30 $7,769
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.202B $7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.949B 32.62
Zoetis (ZTS) United States $74.394B 27.76
Takeda Pharmaceutical (TAK) Japan $48.493B 9.65
Daiichi Sankyo, - (DSNKY) Japan $47.908B 24.55
BeOne Medicines - (ONC) Cayman Islands $28.843B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.294B 0.00
Merck (MKKGY) Germany $17.183B 12.59
Summit Therapeutics (SMMT) United States $16.398B 0.00
Shionogi (SGIOY) Japan $14.377B 14.40
United Therapeutics (UTHR) United States $12.691B 11.23
Neurocrine Biosciences (NBIX) United States $12.348B 42.29
IPSEN (IPSEY) France $10.086B 0.00
Orion OYJ (ORINY) Finland $10.083B 27.27
Corcept Therapeutics (CORT) United States $7.664B 62.30
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.268B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.863B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $4.021B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.209B 11.24
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Crinetics Pharmaceuticals (CRNX) United States $3.097B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.452B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.448B 13.24
BioCryst Pharmaceuticals (BCRX) United States $2.304B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.215B 0.00
Indivior (INDV) United States $1.888B 8.01
Dyne Therapeutics (DYN) United States $1.680B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.619B 0.00
Evotec AG (EVO) Germany $1.467B 0.00
ARS Pharmaceuticals (SPRY) United States $1.443B 0.00
Ocular Therapeutix (OCUL) United States $1.419B 0.00
Guardian Pharmacy Services (GRDN) United States $1.306B 0.00
Harrow (HROW) United States $1.143B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Enliven Therapeutics (ELVN) United States $1.065B 0.00
Akebia Therapeutics (AKBA) United States $1.030B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.990B 0.00
Collegium Pharmaceutical (COLL) United States $0.976B 5.26
Ardelyx (ARDX) United States $0.895B 0.00
Cronos Group (CRON) Canada $0.752B 0.00
Elite Pharmaceuticals (ELTP) United States $0.748B 0.00
Xeris Biopharma Holdings (XERS) United States $0.712B 0.00
KalVista Pharmaceuticals (KALV) United States $0.706B 0.00
Xencor (XNCR) United States $0.693B 0.00
Relay Therapeutics (RLAY) United States $0.598B 0.00
AleAnna (ANNA) United States $0.584B 0.00
Liminatus Pharma (LIMN) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.49
Regulus Therapeutics (RGLS) United States $0.575B 0.00
Verve Therapeutics (VERV) United States $0.569B 0.00
Bioventus (BVS) United States $0.564B 14.29
Altimmune (ALT) United States $0.547B 0.00
Theravance Biopharma (TBPH) United States $0.537B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.513B 0.00
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Oruka Therapeutics (ORKA) United States $0.494B 0.00
Tourmaline Bio (TRML) United States $0.488B 0.00
Siga Technologies (SIGA) United States $0.444B 9.28
Organogenesis (ORGO) United States $0.440B 0.00
Savara (SVRA) United States $0.403B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 10.41
Aquestive Therapeutics (AQST) United States $0.356B 0.00
Heron Therapeutics (HRTX) United States $0.323B 0.00
ProKidney (PROK) United States $0.293B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 24.24
Esperion Therapeutics (ESPR) United States $0.242B 0.00
MediWound (MDWD) Israel $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.229B 0.00
4D Molecular Therapeutics (FDMT) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
OmniAb (OABI) United States $0.188B 0.00
Larimar Therapeutics (LRMR) United States $0.186B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.162B 0.00
Aldeyra Therapeutics (ALDX) United States $0.161B 0.00
Lyell Immunopharma (LYEL) United States $0.160B 0.00
Avita Medical (RCEL) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Nektar Therapeutics (NKTR) United States $0.141B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.129B 0.00
Achieve Life Sciences (ACHV) Canada $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Fractyl Health (GUTS) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Wellgistics Health (WGRX) United States $0.102B 0.00
Inotiv (NOTV) United States $0.098B 0.00
OptiNose (OPTN) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Champions Oncology (CSBR) United States $0.089B 14.68
Nutriband (NTRB) United States $0.086B 0.00
Galectin Therapeutics (GALT) United States $0.085B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.082B 61.22
Dominari Holdings (DOMH) United States $0.080B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Rafael Holdings (RFL) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Klotho Neurosciences (KLTO) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
NRx Pharmaceuticals (NRXP) United States $0.063B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
Century Therapeutics (IPSC) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Carisma Therapeutics (CARM) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
China SXT Pharmaceuticals (SXTC) China $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.033B 0.00
Jupiter Neurosciences (JUNS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Relmada Therapeutics (RLMD) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Lyra Therapeutics (LYRA) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Vivos Therapeutics (VVOS) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00